Education
About Us
Working with TipRanks
Follow Us
Klotho Neurosciences (KLTO)
NASDAQ:KLTO
KLTO Stock Chart & Stats
$0.36
-$0.02(-3.27%)
At close: 4:00 PM EST
$0.36
-$0.02(-3.27%)
Day’s Range― - ―
52-Week Range$0.11 - $3.91
Previous CloseN/A
Volume261.47K
Average Volume (3M)876.92K
Market Cap
$26.16M
Enterprise ValueN/A
Total Cash (Recent Filing)$7.35M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding72,536,720
10 Day Avg. Volume693,655
30 Day Avg. Volume876,920
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)7.88
Price to Sales (P/S)0.00
P/FCF Ratio-3.04
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Klotho Neurosciences News
KLTO FAQ
What was Klotho Neurosciences’s price range in the past 12 months?
Klotho Neurosciences lowest stock price was $0.11 and its highest was $3.91 in the past 12 months.
What is Klotho Neurosciences’s market cap?
Klotho Neurosciences’s market cap is $26.16M.
When is Klotho Neurosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Klotho Neurosciences’s earnings last quarter?
Currently, no data Available
Is Klotho Neurosciences overvalued?
According to Wall Street analysts Klotho Neurosciences’s price is currently Overvalued.
Does Klotho Neurosciences pay dividends?
Klotho Neurosciences does not currently pay dividends.
What is Klotho Neurosciences’s EPS estimate?
Klotho Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Klotho Neurosciences have?
Klotho Neurosciences has 72,536,720 shares outstanding.
What happened to Klotho Neurosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Klotho Neurosciences?
Currently, no hedge funds are holding shares in KLTO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Klotho Neurosciences
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Technical Analysis
ProMIS Neurosciences
―
Annovis Bio
―
Lantern Pharma
―
Generation Bio
―
Neurosense Therapeutics Ltd.
―
Ownership Overview
9.80% Insiders
0.67% Mutual Funds
0.01% Other Institutional Investors
89.04% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---